Integration of (68)Ga-PSMA-PET imaging in planning of primary definitive radiotherapy in prostate cancer: a retrospective study.
about
Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients.Intermediate-term outcome after PSMA-PET guided high-dose radiotherapy of recurrent high-risk prostate cancer patients.Impact of 68Ga-PSMA PET/CT on salvage radiotherapy planning in patients with prostate cancer and persisting PSA values or biochemical relapse after prostatectomy.68 Ga-PSMA-PET for radiation treatment planning in prostate cancer recurrences after surgery: Individualized medicine or new standard in salvage treatment.Detection level and pattern of positive lesions using PSMA PET/CT for staging prior to radiation therapy.(68) Ga-PSMA PET/CT for the detection of bone metastases in prostate cancer: a systematic review of the published literature.The feasibility of prostate-specific membrane antigen positron emission tomography(PSMA PET/CT)-guided radiotherapy in oligometastatic prostate cancer patients.Clinical impact of 68 Ga-prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) in patients with prostate cancer with rising prostate-specific antigen after treatment with curative intent: preliminary anaAdvances in prostate-specific membrane antigen PET of prostate cancer.Patterns of failure after radical prostatectomy in prostate cancer - implications for radiation therapy planning after 68Ga-PSMA-PET imaging.Impact of 68Ga-PSMA-PET imaging on target volume definition and guidelines in radiation oncology - a patterns of failure analysis in patients with primary diagnosis of prostate cancer.PSMA-PET based radiotherapy: a review of initial experiences, survey on current practice and future perspectives.
P2860
Q36377961-A2334AE6-68F8-4A16-B2E4-85A5634E4AE7Q37662669-D8BA0E27-18ED-4E7A-A931-1D8E256AC22CQ38613594-56AFD159-721B-4DB3-B1AA-E902E2D33F94Q38804450-0972BECF-F897-4970-92C7-27AF1BBD6486Q38895102-70DC2FB9-2C08-4973-A744-A05BA6E6C663Q47107456-FA7C288B-5012-4C0D-94B2-D1F344B688FBQ47693515-FE2BB502-BE7A-4A8C-BA26-874B6FF1B25FQ48262413-580F4356-4F1F-4C7D-8D03-9766113B4E93Q48898788-2974233E-E927-4FA3-951D-90735720B2B8Q49713199-44316258-128A-4D3A-8724-732D3AA31DBDQ51840218-84B71BA4-099B-4AC1-9424-E004EC8D6A94Q52680980-727ADE93-CB55-4225-8DA7-BD1B3574FAF8Q55399763-D43DF5A0-9A91-4A49-B53B-2AB12345B4E3
P2860
Integration of (68)Ga-PSMA-PET imaging in planning of primary definitive radiotherapy in prostate cancer: a retrospective study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Integration of (68)Ga-PSMA-PET ...... cancer: a retrospective study.
@en
type
label
Integration of (68)Ga-PSMA-PET ...... cancer: a retrospective study.
@en
prefLabel
Integration of (68)Ga-PSMA-PET ...... cancer: a retrospective study.
@en
P2093
P2860
P1433
P1476
Integration of (68)Ga-PSMA-PET ...... cancer: a retrospective study.
@en
P2093
Gregor Habl
Jürgen E Gschwend
Katharina Sauter
Kilian Schiller
Markus Schwaiger
Matthias Eiber
Sabrina Dewes
P2860
P2888
P356
10.1186/S13014-016-0646-2
P577
2016-05-26T00:00:00Z
P6179
1020421272